What is Immunotherapy? Difference from Chemotherapy and Cuba’s Position in This Field

Recognized as a groundbreaking approach in modern oncology, cancer immunotherapy methods revolutionize the healing process by reorganizing the body’s own defense mechanisms against tumor cells. So, what is Immunotherapy, a term we frequently hear in the medical world in recent years? In this article, we will comprehensively cover all the curious details regarding immunotherapy treatment, its processes, and Cuba’s pioneering role in this field.

What is Immunotherapy?

Also referred to as biological therapy, this method is a type of medical intervention that strengthens and guides the body’s immune system to fight cancer. The clearest answer to the question “what does immunotherapy mean?” is to block the signals that allow cancerous cells to escape the defense system, thereby ensuring that immune cells recognize and destroy the tumor. Instead of delivering an external poison to the body, the medications used in this process make the internal protective cells smarter and more aggressive.

How Does the Immune System Work Against Cancer?

The immune system, which is the natural defense line of our body, is responsible for detecting and destroying foreign microbes and faulty cells through specialized units such as T-cells and B-cells. Under normal conditions, this system can detect cancerous cells with damaged DNA structures right at the beginning of the road and drive them to programmed cell death (apoptosis). However, cancer cells evolve over time, developing special protein shields that make them appear as healthy tissue and successfully escaping the “radar” of immune cells. This situation sets the stage for the tumor to grow without encountering any resistance inside the body, invade tissues, and spread to distant organs through the bloodstream.

Antigen-presenting cells, which are among the most vital actors in the immune system’s struggle against cancer, issue instructions to the defense units by extracting the fingerprint of the cancerous tissue. If these communication channels are open, the body can restrict and completely eliminate malignant masses without needing any external support. However, cancer’s spreading strategy is built precisely on disrupting this communication network and putting defense cells into a sort of “sleep mode.”

How Does Immunotherapy Activate This System?

Cancer immunotherapy protocols reactivate the system by releasing the “brake” mechanisms that tumor cells use to mislead the immune system. These medications work like biological stimuli that unlock the T-cells, triggering them to attack the cancerous tissue with a much higher sensitivity and speed. Some methods support the system by sending anti-tumor warriors into the body from the outside or by developing the ability of immune cells to recognize antigens in a laboratory environment. As a result, the potential power that already exists within the body but has been blocked is brought to light once again through medical intervention.

The primary goal in this process is not only to destroy the existing tumor but also to provide the immune system with a memory, thereby preventing the cancer from recurring in the future. Immunotherapeutic agents form a permanent protective shield that ensures immune cells react immediately to the cancerous tissue once they recognize it, whenever they encounter it again anywhere in the body. This biological modulation turns the patient’s own cells into medications, transforming the treatment into a systemic and continuous process. Thus, unlike classic methods that directly target the tumor, the body’s defense mechanism undergoes a complete transformation from top to bottom.

What Are the Types of Immunotherapy?

The methods used in modern oncology are divided into highly technical and advanced categories that differ from each other according to the way they stimulate the immune system. Spanning a wide spectrum from checkpoint inhibitors to special cancer vaccines, this broad range is selected according to the genetic map of the patient and the molecular features of the tumor. Each type aims to optimize the capacity to fight cancer by repairing or strengthening a different weak point of the body’s defense mechanism. Thanks to this diversity, successful results can be achieved by trying different combinations in resistant cancer types that do not respond to a single treatment.

Checkpoint Inhibitors

Checkpoint inhibitors are the most common type of immunotherapy that releases the natural “brakes” on immune cells (T-cells), allowing them to work at full capacity against cancer. Cancer cells use proteins like PD-1 or CTLA-4 to send a “I am a friend, do not attack me” signal to the immune system, securing themselves. These medications, on the other hand, drop this mask of cancer by blocking the signals in question and ensure the immune system initiates the attack order. Used especially in aggressive types such as lung cancer and melanoma, this method plays a vital role in ensuring the immune system sees the tumor as an “enemy” once again.

Monoclonal Antibodies

Produced in a laboratory environment, these special proteins are designed to lock directly onto specific targets on cancer cells to mark them after being injected into the body. While some monoclonal antibodies possess a function that merely marks the cancer cell so that the immune system can find it more easily, some directly cut off the growth signals of the cell, triggering it to die. Since this method keeps the damage given to healthy tissues at a minimum, it is also evaluated in the “smart drug” category, providing a precise focus in treatment. These point-blank interventions occurring at the cellular level offer a much more targeted treatment discipline compared to traditional methods.

Cancer Vaccines

Cancer vaccines, unlike classic virus vaccines, train the immune system against specific tumor antigens with the aim of treating an already existing disease or preventing its recurrence. These vaccines introduce protein fragments belonging to cancerous cells to the body, ensuring the defense system stays in a continuous state of alarm against these cells and destroys them wherever it sees them. Especially vaccines developed in Cuba, such as CIMAvax-EGF, aim to bring the disease into a manageable chronic condition by cutting off the resources cancer needs to grow. This approach builds a long-term survival strategy by bringing the patient’s immune power to the highest level.

CAR-T Cell Therapy

CAR-T cell therapy is the process of taking T-cells from the patient’s own blood, modifying them genetically in a laboratory environment, and equipping them with special receptors that recognize cancer cells. When these cells, transformed into “super warriors,” are delivered back into the patient’s body, they begin to destroy their targets in a rapid sequence. This method is an extremely advanced and personalized wonder of genetic engineering that can yield miraculous results, especially in blood cancer types. Recognized as one of the most sophisticated treatment methods in oncology, this technology makes the immune system stronger by directly intervening in its genetic code.

Differences Between Immunotherapy and Chemotherapy

One of the questions patients ask most frequently during the cancer treatment process is “chemotherapy or immunotherapy?”. The fundamental reason for this comparison is that the two methods follow different paths in fighting the disease. While chemotherapy targets the destruction of all rapidly dividing cells in the body without discrimination, cancer immunotherapy methods create an indirect but much more specific effect by merely training the defense system. This basic distinction directly impacts many elements, from the success of the treatment to the patient’s daily quality of life. Although both methods possess their own unique advantages, modern medicine now tends to combine these two powers to complement each other.

Difference in Terms of Mechanism of Action

Chemotherapy is a “cytotoxic” method; meaning it physically dismantles cancer cells by directly attacking their DNA or division mechanism. However, during this attack, healthy tissues that divide rapidly in the body, such as hair cells, the digestive system mucosa, and blood cells, also suffer serious damage. In contrast, the mechanism of action of immunotherapy targets the body’s own defense cells, not the cancer directly. Immunotherapy drugs are biological messengers, conducting a more natural and target-oriented process by having the immune cells do the core work.

Difference in Terms of Side Effects

The fundamental distinction between chemotherapy and immunotherapy is hidden within the quality and timing of the damage they create in the body. While evaluating the question “chemotherapy or immunotherapy?”, knowing the impacts of both methods on the body is decisive regarding treatment comfort.

To see the differences more clearly, the following points stand out:

• While chemotherapy directly kills the cell, immunotherapy trains the immune system.
• While chemotherapy effects are seen immediately, immunotherapy effects can start even months later.
• While fatigue and hair loss are intense in chemotherapy, the skin and hormone system are affected more in immunotherapy.
• While the side effects of immunotherapy can rarely be permanent (such as thyroid damage), chemotherapy effects generally pass when the treatment ends.

Due to these structural differences, the management of both treatments requires different expertise and is meticulously planned according to the patient’s general health profile.

Under Which Conditions is Which One Preferred?

When deciding on “chemotherapy or immunotherapy?”, oncologists focus on the biological stage of the tumor, its genetic mutations (for example, the PD-L1 level), and the general physical condition of the patient. Some tumors are described as “cold” tumors and do not respond to immunotherapy; in this case, chemotherapy is still the first and strongest option. However, in “hot” tumors where immune cells are intensely present, immunotherapy can deliver far superior results than chemotherapy in extending lifespan. Today, in many protocols, combination treatments are preferred where chemotherapy is used to weaken the tumor and expose its antigens, and then immunotherapy is used for the system to recognize these antigens.

In Which Cancer Types is Immunotherapy Used?

Initially receiving approval in only a limited number of cancer types, this method is successfully applied across a very broad disease group today with scientific research gaining speed. Especially the long-term survival rates it delivers in cases that have reached the metastatic phase and developed resistance to all other treatments expand the usage area of this treatment day by day.

Since cancer immunotherapy applications focus on the tumor’s interaction with the immune system rather than which organ of the body it is located in, it generates excitement across many different branches. Following its striking success in lung and skin cancer, it has now become a promising option in kidney, bladder, head-neck, and even some breast cancer types as well.

Immunotherapy in Lung Cancer

Lung cancer is at the forefront of the fields where immunotherapy yields the most successful results and completely changes treatment standards. Especially in non-small cell lung cancer (NSCLC) cases, the survival times of patients can be dramatically extended thanks to immune checkpoint inhibitors. Plans made by looking at the rate at which the tumor expresses the protein called PD-L1 play a critical role in predicting the success of the treatment beforehand. Some patients can carry their diseases to a manageable and stable phase with immunotherapy after years of chemotherapy sessions.

Immunotherapy in Skin Cancer (Melanom)

Although melanoma is the most lethal type of skin cancer, it is the type that benefits most from this treatment because it is among the immunogenic tumors that stimulate the immune system the most. While options were highly limited for metastatic melanoma patients in the past, huge increases are observed in five-year survival rates today thanks to immunotherapy. When the barriers preventing the immune system from recognizing melanoma cells are lifted with these drugs, the body can sometimes completely destroy dozens of tumor centers that have spread throughout the body. This success has been one of the first and greatest proofs solidifying immunotherapy’s place in the oncology world.

Its Use in Other Cancer Types

The success of these methods has not remained limited to lung and skin alone; it has also been proven effective in renal cell cancers, head-neck tumors, and lymphomas that do not respond to classic treatments. Immunological agents used in the treatment of bladder cancers in urological oncology offer a powerful alternative for patients who have lost the chance of surgery. Additionally, in specific genetic subtypes of colon cancer (MSI-H), immunotherapy displays a much higher efficacy than traditional chemotherapy. Receiving approval through new clinical studies every passing day, this method moves forward with firm steps toward becoming the core building block of cancer treatment in the future.

Advantages and Limitations of Immunotherapy

Although immunotherapy is viewed as a miracle in oncology, like every medical intervention, it harbors both great advantages and significant limitations that need to be overcome within itself. The greatest plus of this treatment is that, thanks to the permanent memory it provides to the immune system, the body continues to resist cancer even after the treatment. However, the fact that this powerful mechanism does not work the same way in every patient and risks such as immunotherapy side effects require the process to be managed very carefully.

Why Can’t Every Patient Benefit from Immunotherapy?

The primary reason immunotherapy does not demonstrate the same effect in every patient stems from the fact that the “tumor microenvironment,” which is the protective shield the cancer creates around itself, changes from person to person. Some tumors are of a “cold” character, meaning they do not harbor immune cells around them, and therefore there is no “army” for immunotherapy drugs to stimulate. Additionally, if the tumor’s mutation load is low, the immune system cannot differentiate the cancerous cell from the healthy one and cannot initiate an attack. Therefore, to determine patients’ eligibility for treatment, genetic tests and biomarker analyses must be performed first, and expectations should be shaped in light of these data.

What Are Immunotherapy Side Effects?

Immunological agents used in the struggle against cancer can cause the body to attack its own tissues as well, since they make the defense system very powerful. The most common immunotherapy side effects that can affect patients’ quality of life are:

• Skin Reactions: Severe itching, redness, and widespread rashes.
• Digestive Problems: Persistent diarrhea due to intestinal inflammation (colitis).
• Hormonal Disorders: Underactivity or overactivity of the thyroid gland, pituitary gland insufficiency.
• General Symptoms: Extreme fatigue, mild fever, and joint pains.
• Organ Inflammation: Inflammatory conditions developing in the lungs (pneumonitis) or liver (hepatitis).

Why is Cuban Immunotherapy Different?

Cuba applies immunotherapy from a different and more holistic perspective than the rest of the world, with its decades-long biotechnology investments and unique research in the field of oncology. The vaccines and molecular treatments they have developed are based on the principle of starving the tumor and stopping its spread by targeting the growth factors of cancer. This strategic difference ensures that the side effect profile of Cuban treatments is lower and allows patients to receive treatment while continuing their daily lives. While immunotherapy is generally an expensive and aggressive process in the rest of the world, Cuba produces more accessible and body-friendly solutions.

Cuba’s Immune System-Oriented Approach

Cuba’s oncology philosophy is built on bringing the immune system to a level where it can cope with the cancer, rather than scraping and throwing the cancer out of the body at once. This approach covers a precise training process through specific antigens without putting the immune system under excessive stress. Cuban biotechnology centers aim to keep the tumor asleep by blocking the feeding pathways of cancer, especially through treatments that block growth factor receptors. Seeing the body’s defense mechanism as an ally, this vision offers a balanced treatment model that slows down the aggressive progress of cancer while preserving the patient’s life energy.

CIMAvax-EGF and Vaxira: Among the Few Cancer Vaccines in the World

Revolutionizing lung cancer treatment, CIMAvax-EGF is a vaccine that cuts off the growth signals of the tumor by ensuring antibodies are produced against the epidermal growth factor (EGF) in the body. Vaxira, on the other hand, is another powerful Cuban vaccine that triggers the immune system to destroy these cells by targeting specific gangliosides on the surface of tumor cells. When these two vaccines are used in patients who have stabilized after chemotherapy, they significantly extend the recurrence period of the disease and enhance the quality of life. Managing only biological signals without creating chemical poisoning, these vaccines are the most concrete successes proving Cuba’s world leadership in oncology.

Nimotuzumab (CIMAher): Target-Oriented Biotechnological Solution

Nimotuzumab is a very special monoclonal antibody that blocks EGFR receptors vital for the growth of cancer cells but does not damage healthy cells. The greatest difference of this drug is that it possesses a much lower toxicity compared to its Western counterparts and next to never leads to severe side effects like skin rashes. Delivering effective results in head-neck, pancreatic, and esophageal cancers as well, this treatment allows the patient to fight cancer without compromising their life comfort. Nimotuzumab is an important molecule representing the high level Cuba has reached in “smart drug” technology and its patient-centered treatment approach.

What is the Difference from Standard Immunotherapies?

While immunotherapies in the Western world generally release the brakes in the immune system completely, sometimes creating severe immunotherapy side effects, Cuban treatments follow a more instructive and selective path. The methods Cuba has developed sabotage the survival mechanisms of the tumor rather than putting the system into a direct conflict with it, making it an easy target for the immune system. Additionally, the application of these treatments is generally in the form of simpler injections and is a process whose follow-up is possible in the comfort of home, not requiring hospitalization. Not tiring the patient economically and biologically, these approaches are the product of a vision to reduce cancer to the category of a manageable “chronic disease.”

Who Can Apply for Immunotherapy in Cuba?

For patients who want to benefit from advanced immunotherapy protocols in Cuba, there are specific medical criteria and an evaluation process. The basic rule is that the patient’s current condition must possess the biological potential to respond to these innovative treatments.

Eligibility Criteria

The most important criterion for treatment eligibility is that the type and stage of cancer overlap with the vaccine or drug protocols in Cuba. It is requested that the patient’s general health status be strong enough for the immune system to respond to these stimuli and be at a level (performance status) to act on their own. Additionally, it is mandatory for cardiac, liver, and kidney functions to possess a certain stability for the treatment to be conducted safely. Eligibility approval is granted not merely based on reports, but as a result of Cuban experts deeply examining the individual data of each patient.

How Does the Application Process Work?

The application stage starts with professionally compiling all current reports, radiological images, and pathology results in the patient’s possession and forwarding them to the relevant medical center in Cuba. This submitted medical file is examined by Cuban experts within 5 to 10 business days, and an official report is presented regarding whether the patient is eligible for treatment. For patients who receive approval, a treatment calendar is prepared, online doctor consultations are organized, and hospital appointments in Cuba are planned. Moving forward under the guidance of an expert consultation instead of the patient managing this entire process on their own guarantees overcoming bureaucratic obstacles and reaching the correct medical channels.

Reach Advanced Cancer Treatments in Cuba with Professional Guidance
If you want to go beyond classic methods in your fight against cancer and strengthen your immune system with Cuba’s innovative oncology solutions, we stand by you as QBA Medi Tours. You can contact our expert team to have your medical reports examined by boards approved by the Cuban Ministry of Public Health, to plan your online doctor consultations, and to organize all the details of your treatment journey. To look to the future with hope and activate your body’s own defense power, fill out our form today and take the first step with us.

Frequently Asked Questions

Is Immunotherapy an Expensive Treatment?

Compared to traditional chemotherapies, immunotherapy drugs are among the highly high-cost treatments in the world due to biotechnological challenges in their production processes. However, Cuba can offer these advanced treatments at international standards to patients with much more accessible budgets compared to the world general, through the vaccines and drugs it has developed within its own healthcare system.

Can Immunotherapy Be Applied Together with Chemotherapy?

Yes, today in many oncological protocols, chemotherapy and immunotherapy are applied in combination; while chemotherapy kills and dismantles tumor cells, immunotherapy builds a stronger defense line by introducing these released cell fragments to the body’s immune system. The combined use of these two methods delivers a much higher efficacy and a permanent response rate in many cases compared to their application alone.

Can Cuban Immunotherapy Be Done in Turkey?

Although it is possible to reach some medications through individual import pathways, starting the process on-site is recommended since the precise dosage and expert supervision offered by the centers in Cuba are critical to obtaining high efficiency in treatment. Professional clinical follow-up in Cuba allows protocols to be updated instantly according to the patient’s biological response, directly impacting the success of the treatment.